Untitled
2021-12-10 • Jay Sharma
The Oxycodone Market is estimated to grow from USD 5.23 Billion in 2020 to USD 7.46 Billion by 2028, at a CAGR of 4.6%, during the forecast period. The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases such as cancer and HIV and a high increase in the prescription of post-operative pain medication.
Cancer's growing commonness, Parkinson's disease, and rheumatic diseases drive the growth of the market. The use of oxycodone to relieve post-operative pain under different medical conditions fuels the growth of the market.
Increasing concern about oxycodone abuse, however, is curbing market growth. However, less addictive oxycodone drugs approved by the FDA for adults and children are likely to open new gateways in the forecast period for the growth of Oxycodone Market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1286
Further key findings from the report suggest